period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.7,0.5,0,0.4166666666666667,[0],The FDA is monitoring the emerging market disruptions for [Drug Name] due to a manufacturer issue. We encourage voluntary reporting from other manufacturers and stakeholders to better assess the market conditions. Patient safety remains our priority.
1,1.2,0.7,0.5,0,0.4166666666666667,[0],The FDA is aware of emerging supply issues and is closely monitoring the situation. We encourage manufacturers and stakeholders to report any disruptions proactively.
